IOL Chemicals and Pharmaceuticals Limited - Neraca (Quarterly)

IOL Chemicals and Pharmaceuticals Limited
IN ˙ NSEI
₹ 96.93 ↓ -1.15 (-1.17%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca IOL Chemicals and Pharmaceuticals Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
03-31
2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
Cash 2,814 323 3,112 32 608 14 587 77 1,509 782
Change (%) -88.51 862.34 -98.96 1,781.11 -97.71 4,123.74 -86.90 1,862.03 -48.19
Assets Current 9,096 10,223 10,782 10,808 9,794 9,204 9,193 11,198 10,857 11,513
Change (%) 12.39 5.47 0.24 -9.38 -6.02 -0.11 21.80 -3.04 6.05
Assets 14,536 16,101 17,640 19,623 20,110 20,221 20,814 22,444 22,651 23,821
Change (%) 10.76 9.56 11.24 2.48 0.55 2.93 7.83 0.92 5.16
Liabilities 3,589 3,497 4,186 5,700 5,690 5,144 4,917 6,329 6,058 6,944
Change (%) -2.56 19.73 36.16 -0.18 -9.59 -4.42 28.72 -4.28 14.62
Equity 10,948 12,604 13,454 13,923 14,421 15,077 15,897 16,115 16,593 16,877
Change (%) 15.13 6.74 3.49 3.58 4.55 5.44 1.37 2.96 1.71
Liabilities And Stock Equity 14,536 16,101 17,640 19,623 20,110 20,221 20,814 22,444 22,651 23,821
Change (%) 10.76 9.56 11.24 2.48 0.55 2.93 7.83 0.92 5.16

Source: Capital IQ

Other Listings
IN:524164
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista